← Back to all trials
Not Yet Recruiting
NCT05746390
Home Alone: An Intervention for People With Cognitive Impairment Who Live Alone
Conditions: Cognitive Impairment, Dementia, Memory Loss
Sex: All
Ages: 55 Years – N/A
Phase: NA
Enrollment: 65
Sponsor: University of Minnesota
Summary
The goal of this clinical trial is to evaluate a program for adults who live alone and have some cognitive impairment (CI) to see if it is useful and acceptable.
This program aims to help older adults with cognitive impairment who live alone to be engaged and active, as well as safe at home.
The investigators want to see how useful this program is and how it can be improved.The specific aims are:Specific Aim 1: Develop and Adapt Home Alone to Prepare for Pilot Testing.Specific Aim 2: Pilot Test a Revised Version of Home Alone.Phase I participants will be asked to:Participate for 3 monthsComplete 3 surveysComplete 7 1-hour meetings on a weekly basis with a coachComplete a final interviewPhase II participants will be asked to:Participate for 6 monthsComplete 3 surveysComplete 7 1-hour meetings on a weekly basis with a coachA sub-sample will be asked to complete a final interview
Eligibility Criteria
Inclusion Criteria:55 years of age or olderLives alone in a non-residential settingEither a provider diagnosis of MCI or presence of cognitive impairment is suggested via administration of the Montreal Cognitive Assessment by telephone (T-MoCA; a score between 13 and 18)Resides in the USDemonstrates capacity to consentExclusion Criteria:Those who do not meet the inclusion criteria above are not eligible.
Additionally, researchers would exclude those who:Live in assisted living, a group care home, or similar residential setting that provides care and servicesAre not English speakingAre currently participating in any other type of service that provides one-to-one psychosocial consultation or independent living coachingHave a new or worsening mental health condition and are not receiving ongoing treatmentHave not remained on a stable psychotropic medications dosage, such as antidepressants, anxiolytics, or anti-psychotics, for the prior three monthsAre not willing/interested in participating or cannot actively participate in the intervention, per researcher discretion
Source: ClinicalTrials.gov (NCT05746390). StuddyBuddy aggregates publicly available trial information.